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This report describes the results of a survey undertaking by NatMEG (the Swedish 
national facility for magnetoencephalography; www.natmeg.se), performed under the 
auspices of Swedish Bioimaging. Swedish Bioimaging is a national infrastructure 
formed in 2010 for the biological and medical imaging field, and has served as an 
umbrella organization for three nationally commissioned medical imaging facilities: 
PET-MR at Uppsala University, MEG at Karolinska Institutet and ultra-high-field MRI 
(from here on abbreviated '7T') at Lund University. For more information about 
Swedish Bioimaging, please see visit www.bioimaging.se.
The three Swedish national imaging facilities (MEG, 7T MRI, PET-MR) are all fairly new 
and their user base and establishment for applications in research and clinical 
applications is not complete. They are also in various phases of adoption, for which 
reason it could be expected that operating models for such facilities are varying. 
     The aim of the survey was to understand the operating environments and 
operating models of such imaging facilities within a European context, as well as the 
circumstances under which the facilities have been installed. Possibly even the survey 
could shed a little light on how to facilitate adoption and progress further. The survey 
was done as an academic project, with no business agenda. 
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A web-based survey was sent to imaging laboratory directors of the three modalities 
in Europe, intending to cover all such facilities currently operating in Europe.
The contacted persons were located using both existing personal contacts and various 
open directories. The number of initial contacts made per modality were:
PET-MR  47, MEG  46, and 7T  29.
The first pages contain a quick summary list of the survey questions, and a summary of 
typical answers.
     On subsequent pages the responses are presented question by question. The final 
pages contain general discussion and conclusions from the survey.
In appendix pages at the end, the answers from the Swedish facilities are presented 
side by side with the typical answers summary 
The data collection took place from May to August 2017, and produced responses 
from 7 different countries for PET-MR, 11 countries for MEG, and 10 countries for 7T. 
The represented countries were: Austria, Belgium, Denmark, Finland, France, Germany, 
Greece, Italy, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, and UK. The 
number of responses received were: PET-MR n=9; (response rate) 19%, MEG n=21; 
46%, 7T n=15; 52%.
     A few responses were incomplete, most commonly regarding the possibly more 
complicated or sensitive business-related questions towards the end of questionnaire. 
Therefore, the number of answers decreases slightly towards the end. A few responses 
were also disregarded, as those suggested that the answers pertain to multiple 
modalities put together, while modality specific answers were the intended goal.
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Survey questions, quick list
shortened texts,
complete question texts presented on the page titles for each individual question
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MEG 7T PET-MR
Q2 Opening year of facility 2006 2011 2014
Q3 Existence of prior peer facilities Yes No Yes
Q4 Peers today in same country Yes Yes Yes
Q5 Distance to nearest peer 100 - 300 km 100 - 300 km > 300 km
Q6a
Q6b
Q7a
Q7b
Q8 National mission Yes Yes No
Q9 European mission No No No
Q10 User origin
Local users Majority Majority Majority
National users Some Some Some
European users Some Some Some
International users Some Some None
Q11 Users' fields of operation
Basic research Majority Majority None
Clinical research Several Several Majority
Clinical applications Some Some Some
Method development Some Several Some
Instrumentation None Some Some
Q12
Local users Cost Cost Cost
National users Cost Cost Cost
European users Cost Cost Cost
International users Cost Cost Cost
Q13 Usage offerings and pricing
Independent use Cost Cost Not offered
Assisted use Cost Cost Not offered
Full service Cost Cost Cost
Q14 Support offerings and pricing
Technical support Free Free Free
Scientific support Free Free Free
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Analysis support
Access & pricing based on origin
Comprehensive
Comprehensive
Local expertise about modality prior 
to installation
National expertise about modality 
prior to installation
Local expertise about modality 
today
National expertise about modality 
today
Comprehensive
Limited
Survey questions, the typical
*
 answer summary
*
mode value or mean value
Limited Limited
Comprehensive
Broad Broad
Comprehensive
Free Cost / Free
Comprehensive Comprehensive
Cost / Free / 
Not offered
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MEG 7T PET-MR
Q15 Training offerings and pricing
Usage training Free Free Not offered
Operating certification Not offered Free Not offered
Data analysis training Free Not offered Not offered
Q16 Use cost / hr 300 € 700 € 200 €
Q17 Support cost / hr 0 € 150 € 200 €
Q18 Reimbursements No No No
Q19 Scientific contribution guidelines Yes Yes No
Q20 Facility installation funding
Q21 Facility availability (days) 300 - 365 300 - 365 200 - 300
Q22 Utilisation rate 60 - 80% 60 - 80% 80 - 100%
Q23 Number of subjects 100 - 200 > 300 200+
Q24 Number of patients 50 - 100 0 > 300
Q25 Operating budget 1 000 k€
*
1 000 k€
*
with national mission 400 k€
without national mission 200 k€
Q26 Maintenance budget 150 k€ 400 k€ 250 k€
Q27 Usage income 50 k€
*
500 k€
*
with national mission 225 k€
without national mission 100 k€
*)
 Number of answers insufficient for meaningful split. 5 / 40
Not offeredFree
Free / Not 
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Theoretical training
National 
infrastructure 
investment
National 
infrastructure 
investment
Local 
investment
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The survey started with establishing the respondent's modality which is the key 
dimension. Nearly all questions are handled with a split along the modality.
Another encompassing dimension is the presence of similar facilities, both at the time 
of installation and today, which are combined in the diagrams above.
Q1 What is the imaging modality of your facility?
vs Q3 When your facility was opened, did similar facilities
           exist in the same country?
vs Q4 And today, do similar facilities exist in the same
          country?
One of the original starting points for the survey was an interest in whether the 
presence of peer sites would affect the operations of the facilities, either via higher 
expertise levels, or via higher national interest and better national utilization of the 
expensive equipment. This assumption will be revisited alongside further questions.
The MEG modality could be interpreted to have the lowest speed of adoption, 
interpreted from there being nearly the same amount of "lone wolfs" today as 
"pioneers". This even despite the MEG installations being earliest in time (ref. Q2 
Opening year). This may also be associated with lower utilization rates (ref. Q22), that 
translate into fewer new installations.
With the phrase "similar facility" a facility having the same imaging modality is 
intended, and further on, such are synonymously also called "peers" for short.
The phrasing regarding "When -- facility was opened, did -- exist" will be shortened 
to "prior to installation" or even "prior" further on.
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The answers here reflect also the differing age of the underlying technologies.
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As a consequence, one could expect the different modality facilities to have accrued 
significantly different amount of operating experience. Operating experience may of 
course be affected by the nature of underlying technology too, for example, whether 
the technology is more or less evolutionary vs. revolutionary, or a hybrid of existing 
technologies.
A preliminary assumption about the effect of opening year (or rather the length of 
operations) was that facilities with longer history would have a) higher expertise, and 
b) more established operating methods.
The a-part is visualized in the graph below. From this, one can estimate two-three 
years of operations is needed until attainment of comprehensive expertise.
The b-part was not successfully investigated in this survey.
Q2 When was the facility opened?
Range of opening year + average opening year
1992
1997
2002
2007
2012
2017
PET-MR MEG 7T
1995 2000 2005 2010 2015
Current expertise vs opening year
(size reflects the proportion of sites at that level)
Comprehensive
Broad
Limited
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Subdivision of other questions along this dimension did not yield noteworthy results, 
although that was originally anticipated.
Proximity to the nearest similar facility here has been grouped to roughly a 50-50 
splitting level, "near" (< 100 km) and "distant" (> 100km).
Q5 What is, roughly, the distance to the nearest similar
       facility (within or across borders)?
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< 100 km
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Word local  in this question refers to the host institution, university or hospital.
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As for PET-MR, comprehensive 
expertise has been acquired 
despite the sites having only an 
average establishment year of 
2015. This is possibly assisted 
by nearly full capacity use of 
the facilities (ref. Q22) and 
assumedly clearer clinical 
protocols (ref. Q11).
MEG facilities, on the other 
hand, can be seen to have had 
significantly more modest 
starting levels of expertise 
compared to the other 
modalities.
Q6a What was the local  level of expertise about your
         imaging modality prior to the installation?
vs Q7a expertise today
Across all modalities, the expertise has accrued comfortably and confidence levels are 
high.
It was interesting to notice that sometimes, albeit very rarely, such imaging facilities 
are established with negligible prior expertise.
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Now examining the prior local expertise from previous question against presence of peers.
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PET-MR facilities had starting expertise levels across the scale and fully irregardless of 
presence of peer sites (which were expected to be existing sources of knowledge).
The result from the previous page (MEG facilities' modest prior expertise) is clearly 
explained by the pioneer vs follower status; pioneer MEG sites in a country started 
clearly with low expertise.
7T
Pioneer 7T facilities had wildly varying expertise to start with, which result is left 
without interpretation, but the followers started predominantly from a broad level, 
conveying here some support for the learning effect assumption for followers. That 
follower facilities are founded by people having gathered knowledge in other 
facilities.
PET-MR
MEG
Q6a (cont) What was the local  level of expertise about
        your imaging modality prior to the installation?
vs Q3 peers at the time of installation
Pioneers (see: Q1/Q3) Followers (see: Q1/Q3)
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Q6b What was nationally the level of expertise about
         your imaging modality prior to the installation?
vs Q7b expertise today
This question was presented in the same context with the question about the local 
expertise, suggesting to the responder a ready comparison between local knowledge 
and knowledge otherwise nationally.
requires determined effort. In the context of this survey, this can be related to 
ambitions of a nationally commissoned centre for facilitating the spreading.
National expertise levels as for 
PET-MR were, and are still 
today weaker than local levels 
(ref. Q6a/Q7a). This may be an 
expected circumstance for a 
high-end, new modality about 
which the knowledge is likely 
to be spatially concentrated. In 
such a case spreading 
knowledge nationally probably
MEG sites have nearly exact 
same national expertise today 
as local expertise today (p. 9), 
this for example contrasted 
with discussion in the above 
paragraph about PET-MR.
National expertise levels as for 
7T indicate some knowledge 
accumulation over time, 
although overall remaining 
slightly lower than local 
expertise levels.
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vs Q3 peers at the time of installation
With MEG, again here as in Q6a (p. 10), the pioneers assessed also the national level 
very modestly. But now the followers appreciated greatly the national knowledge. 
This is in contrast to local expertise levels for MEG followers (p. 10) which were 
typically at 'limited' level. In other words, the MEG followers saw themselves often as 
learners from the more experienced groups elsewhere in a nation.
As for PET-MR, the presence of peer sites did not explain any of starting expertise 
variation.
7T
Q6b (cont) What was nationally  the level of expertise
         about your imaging modality prior to the
         installation?
PET-MR
MEG
Pioneers Followers
As to 7T, roughly the same results as for MEG (above), except not quite as polarised 
values.
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Surprisingly, the pioneer sites (= 'No' categories in the left axis labels) in a country 
were not  any likelier to have been given a national mission, except possibly to some 
extent as for 7T.
Q8 Does the facility have an explicit mission to function
      as a national facility?
vs Q3 peers at the time of installation
National missions are commonly occurring. Their exact contents was not surveyed, 
but some split between externally given missions vs internally expressed aspirations 
was seen.
This characteristic is the chief dimension used to split other answers into subgroups.
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Q9 Does the facility have an explicit mission to function
      as a European facility?
Explicit European co-operation missions seem not be a widely occurring arrangement 
yet.
Other modalities that were excluded from this survey are suspected to be more active 
in such arrangements. This result was in line with prior expectation of the 
circumstances.
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7T
MEG
PET-MR
No
Yes
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Q10 Where do your users come from? (consider the Principal
           Investigators only)
However, one could speculate to what extent a strong pocket of local users can be, and 
must be, a facilitator for national adoption.
The three modalities have been grouped together here because the distributions were 
essentially the same for each.
The results here were strongly consistent with expectations. A strong local user group 
is nearly inevitable, and fully understandable.
0% 20% 40% 60% 80% 100%
Share of local users
Majority
Several
0% 20% 40% 60% 80% 100%
Share of national users
Majority
Several
Some
None
0% 20% 40% 60% 80% 100%
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Share of international users (outside Europe)
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It would be reasonable to assume that a nationally commissioned site would attract a 
larger share of national users, probably at the expense of local users, compared to a 
non-commissioned site. But this assumption is not clearly supported by the answers, 
except possibly to a little extent as to MEG sites. The majorities of national users 
occurring for some PET-MR and 7T sites are driven by some other factor than a 
national mission.
A suggested interpretation for this is that use of new technologies/modalities does not 
spread automatically within a country, but rather requires an effort to spread the 
awareness and knowledge. It could be that this is achieved best via strong enough 
local groups, causing natural adoption only over time.
Q10 (cont.) Where do your users come from?
In the end, it is probably secondary whether the users are nationals or locals as long as 
equipment utilization rate is high, and usage overall efficient.
vs Q8 National mission
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The respondents were requested to estimate what share of their users are engaged in 
various fields of activity.
The first diagram here summarizes what share of facility use is comprised of basic 
research users. The results for other fields/domains are on the following pages.
Overall, large variety exists over how extensive basic research use is, as it can vary from 
large majorities to only some users. This suggests some specialization takes
Q11 Within which fields are the users engaged? (consider PIs
          only)
PET-MR differs strongly from other modalities having no site at all predominantly 
involved in basic research and, furthermore, many sites doing no basic research at all.
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Majority
Several
Some
None
Jaakko Lyytinen and Daniel Lundqvist (2017). European Bioimaging Facility Survey Report. 
NatMEG, Department of Clinical Neuroscience, Karolinska Institutet, ISBN 978-91-7676-850-1.
18 / 40
Q11 (cont.) Within which fields are the users engaged?
Again, large variety exists in the share of clinical usage, ranging across whole spectrum, 
from sites with majority of clinical users to no clinical users at all.
Judging from the results, PET-MR is significantly more clinically oriented than other 
modalities, and 7T being furthest away from clinicality.
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The results for these two fields of activity likely reflect the different technological 
maturity of the modalities.
Q11 (cont.) Within which fields are the users engaged?
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vs Q8 National mission
For clarification, the following questions (Q12-Q15) investigate priced vs free 
availability of equipment use, and various associated services.
Q12 Do you offer facility access to PIs from these user
        categories?
At nationally commissioned facilities, also local users are more likely to pay for access. 
This is hinting at aiming for non-preferential treatment of all users. Even a small 
portion of PET-MR sites, naturally without a national mission, go as far as not even 
allowing non-local national users.
As is visible across all modalities in these diagrams, the nationally commissioned 
facilities charge all users more frequently. This is hypothesized to result from more 
thought-out business plans altogether. What effect this has on the efficiency of local 
groups (them having to pay more in such cases) is then another discussion.
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Nationally commissioned sites, overall, offer slightly wider range of equipment 
operating modes. But a clearer effect than that, is that these services are then offered 
for a price rather than free.
vs Q8 National mission
Q13 Are different levels of service offered for using the
        equipment?
Assisted use seems to be the most often offered level of equipment operating 
service, except as to PET-MR where full service clearly is the dominating modus 
operandi. Surprisingly extensively this assisted use is provided for free (although 
possibly included in the hourly price).
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vs Q8 National mission
Q14 Do you offer these types of support to the users?
Nationally commissioned sites do provide slightly more comprehensive assortment of 
services to users. A noteworthy aspect with these three support varieties for MEG and 
7T is that the cost vs free split is nearly 50-50.
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(one further related diagram and interpretations on next page)
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vs Q8 National mission
Q15 Do you offer training to the users?
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Judging from these diagrams, in many cases the national mission sites offer the 
training services more often for free (usage training, PET-MR; theoretical training, PET-
MR & MEG; data analysis training, MEG & 7T) while equipment usage was more often 
priced by them. This might possibly be related to technology adoption spreading 
ambitions.
vs Q8 National mission
Q15 (cont.) Do you offer training to the users?
All training offerings turn out to be significantly less available than support services 
(ref. previous question Q14). However when available, these are usually available for 
free.
Usage training is both predominantly available and usually free, which is probably a 
good thing for technology adoption purposes, but raises question of how that is 
resourced.
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This diagram summarizes free availability of different offerings, both in total 
availability and broken down by modality, finally ordered into a decreasing total 
availability. Clearly some modality specific idiosyncracies in availability are seen.
Considering that, roughly speaking, half of all facilities do offer nearly all these 
services for free and then the other half not for free, this creates a widely varying field 
for end users. Understandably, oftentimes the services availability is also negotiable 
according to the answers.
For comparison with the previous, presented here is a summary of priced availability, 
similarly ordered into a decreasing total availability (note different horizontal order 
from above!).
Summarizing diagrams for Q13-Q15
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Mean values: PET-MR 200 €, MEG 300 €, 7T 700 €
PET-MR modality had only few answers.
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As to national mission's effect, for MEG it can be seen that it brings an hourly cost 
effect of about -100€, for PET-MR and 7T the result is inconclusive.
Q16 What is the hourly cost of the use of the facility for a
        user? (specify the highest charged price if different prices are employed, but
          the price without any extra services included)
Overall, considerable variety exists in hourly price. One could even say that the price 
can be almost anything.
In addition, variety of 'Other' answers existed which were elaborated with e.g. 
commercial vs. academic pricing differences.
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Mean values: PET-MR 200 €, MEG 0 €, 7T 150 €
7T sites are somewhat polarized between 0 € and > 500 €
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Q17 What is the hourly cost of facility support for a user?
        (specify the highest charged price if different prices are employed)
MEG facilities differ clearly from others in that they predominantly do not lay support 
costs upon users.
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The lack of reimbursement policies is more evidence for 7T use not being clinical yet.
This fact may also underlie in the Q16 hourly cost figures.
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Q18 Is there a reimbursement coupled to the use of your
        equipment for specific clinical conditions?
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It could be envisioned that nationally commissioned sites would more rigorously apply 
scientific contribution guidelines (via larger share of collaboration efforts, and 
hypothesized more explicit business plans). This was supported within the MEG 
modality, not so much within the other modalities.
Despite PET-MR facilities having strong emphasis in clinical activities (ref. Q11), they 
are surprisingly not utilizing contribution guideline protocols to large extent, at least 
not explicitly.
Q19 Are guidelines applied to acknowledge
        contributions that have been made during facility
        access, such as Vancouver guidelines?
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Multitple sources of funding were allowed in the question.
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Somewhat surprisingly, a national mission seemed not have had a clear-cut effect on 
the funding source. On the other hand, 7T sites with a national mission used a larger 
variety of funding sources than those without a national mission. But the opposite was 
the case for MEG. Yet the two most common funding sources are the same for both 
modalities, even in equal number of occurrences irregardless of national mission.
vs Q8 National mission
Q20 How was the installation of the facility funded?
The relative size of actual funding received from different the sources was not 
investigated in the survey, something where differences could have possibly been 
found.
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vs Q8 National mission
Q21 For approximately how many days per year is the
         facility open for use?
Only for the 7T modality are the nationally commissioned sites on average significantly 
more open than the non-commissioned sites.
Overall, not many facilities have trouble achieving nearly full availability. Reasons for 
less than full availability were not investigated in this survey.
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vs Q8 National mission
It is seen here that the PET-MR facilities are operating very near capacity, while many 
of the low utilization rate facilities (< 60%) are MEG facilities.
Q22 What is (approximately) the utilisation rate of the
         facility?
Surprisingly, across all modalities, higher utilisation rates are observed where no 
national mission exists. This is interpreted supporting an assumption that it is easier to 
push adoption of a new modality locally. Possibly even the hurdles to initiate imaging 
undertakings are just lower locally as opposed to a national facility.
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vs Q8 National mission
The 7T modality has clearly the highest throughput. An envisioned contributing reason 
is that 7T scans may be faster to execute and thus inherently allow a larger throughput.
The subject amounts of MEG facilities are widely varying, and as such, also reflected in 
utilization rate variety (ref. Q22).
Q23 Approximately how many subjects are examined in
        a year? (with the pertaining imaging modality)
Outside of what is shown in above diagram, one could not see higher subject 
throughputs correlated with older sites, so an assumption of learning effect for the 
operations efficiency fine-tuning was not supported.
Facilities with national mission have slightly higher amount of subjects, except possibly 
as to MEG.
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vs Q8 National mission
The effect from a national mission is mostly indiscernible here. On the other hand, PET-
MRs with a national mission have clearly lower patient throughput, while 7Ts with a 
national mission do have patients much more often.
PET-MR facilities are most clinical clearly, which was also directly reported in Q11 as 
most common users' domain.
Q24 Approximately how many patients are examined in
        a year?
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vs Q8 National mission
For MEG modality, which had sufficiently large number of answers, the operating 
budget answers are here broken down along national mission.
Estimated mean values with this split:
  MEG with national mission 400 000 €
  MEG without national mission 200 000 €
Q25 What is the annual operating budget of the facility?
The answers to this question are meant to represent the budget pertaining to the one 
imaging modality alone. For PET-MR modality there were only very few answers.
Estimated mean values: PET-MR 1 000 000 €, MEG 300 000 €, 7T 1 000 000 €
Obtaining a rough estimate of the budget, and what effect a national mission has on 
the budget, was the intended goal of this question, not a business analysis.
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Estimated mean values: PET-MR 250 000 €, MEG 150 000 €, 7T 400 000 €
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Q26 What are the annual maintenance costs of the
        facility?
In the context of this survey, the maintenance cost levels are meaningful when 
juxtaposed with total operating budget and/or use income.
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Estimated mean values: PET-MR 500 000 €, MEG 125 000 €, 7T 50 000 €
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Estimated mean values:
  MEG with national mission 225 000 €
  MEG without national mission 100 000 €
As to the MEG modality, which had meaningfully enough answers in Q27, the answers 
are here broken down along national mission.
vs Q8 National mission
Q27 What is the annual income from use fees of the
        facility?
PET-MRs have clearly higher incomes. This is likely due to higher number of patients 
examined (ref. Q24).
A noteworthy juxtaposition is that 7T lab incomes are usually low despite high 
operating costs (ref. Q25).
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While the utilization rate in facilities without a national mission is comparatively higher 
than at those with national missions, support ambitions differ in the opposite direction. 
      Facilities with national missions then provide a wider range of services, together 
with an increased staffing, jointly indicating more comprehensive ambitions in 
supporting, teaching and facilitating nationwide adoption of the method.
A key perspective for this survey was that of a facility with  a national mission, as 
compared to those without such a mission.
     The wide range of price points and negotiable components in pricing is interpreted 
to suggest a widely varying operating modes, likely shaping up from local 
circumstances.
Looking at the service offering assortment, it seems that a more clinical nature of 
operations (as is often the case with PET-MR) allows a tighter set of offerings to suffice. 
Training offerings are then also clearly less available than more direct equipment 
support offerings.
     The investigated three modalities, while sharing the nature of a high-end imaging 
modality, each seem to have their own historical/technical idiosyncracies affecting both 
adoption and the operating models.
From a monetary perspective, a national mission seems to bring along a larger budget 
(double), probably corresponding also to larger amount of staff, and via that a 
possibility for a wider service offering. 
     Nationally commisioned facilities, on the other hand, also gain a larger income from 
users (double), seemingly because they offer more comprehensive services to users, 
and also more often charge users for these services.
Somewhat counterintuitive, there is on average a better utilization of equipment in 
labs without a national mission. Whether this is due to stronger local operations, better 
local awareness about equipment or a faster set up of research programs is difficult to 
say. It is also possible that the demand for the equipment preceded the equipment 
investment decision in such cases to a larger extent than cases where national mission 
drove the investment decision. 
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MEG PET-MR 7T
2
Q2 Opening year of facility 2006 2013 2014
Q3 Existence of prior peer facilities Yes No Yes No Yes
Q4 Peers today in same country Yes No Yes
Q5 Distance to nearest peer 100-300km > 300 km > 300 km
Q6b
Q7a
Q7b
Q8 National mission Yes Yes No Yes No
Q9 European mission No No No
Q10 User origin
Local users Majority Several Majority
National users Some Several Some
European users Some Some Some
International users Some None None
Q11 Users' fields of operation
Basic research Majority Several None Some None
Clinical research Several Several Majority Several Majority
Clinical applications Some Some Some Majority Several
Method development Some Some Some Some None
Instrumentation None Some Some
Q12
Local users Cost Cost Cost Cost Free
National users Cost Cost Cost Cost Not off.
European users Cost Cost Cost
International users Cost Cost Cost
Q13 Usage offerings and pricing
Independent use Cost Cost Not off. Not off. Free
Assisted use Cost Free Not off. Not off. Free
Full service Cost Not off. Cost Not off. Free
Q14 Support offerings and pricing
Technical support Free Free Free Cost Not off.
Scientific support Free Free Free Free Not off.
1)
 Two answers.
2)
 No 7T answer for Sweden available. 39 / 40
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Appendix:
The typical answer summary vs Swedish answers
Majority
Some
None
None
Compreh.
Compreh.
Compreh. Limited
Compreh. Compreh. Compreh.
National expertise about 
modality prior to installation
Local expertise about modality 
today
Limited
MEG
Sweden
Local expertise about modality 
prior to installation
Negligible Broad Compreh.
Access & pricing based on origin
Analysis support Free
Cost / Free 
/ Not off.
Compreh. Broad Compreh.
National expertise about 
modality today
Free
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MEG PET-MR
Q15 Training offerings and pricing
Usage training Free Free Not off.
Operating certification Not off. Free Not off.
Data analysis training Free Free Not off. Cost Not off.
Q16 Use cost / hr 300 € 100-200 € 200 € 100-200 € Depends
Q17 Support cost / hr 0 € 0 € 200 € 200-300 € Depends
Q18 Reimbursements No Yes No
Q19 Scientific contribution guidelines Yes Yes No
Q21 Facility availability (days) 300 - 365 200 - 300 200 - 300 300-365 200-300
Q22 Utilisation rate 60 - 80% 40 - 60% 80 - 100%
Q23 Number of subjects 100 - 200 50 - 100 200+ 200-300 100-200
Q24 Number of patients 50 - 100 25 - 50 > 300 100-200 >300
Q25 Operating budget 250 - 500k€ 1 000 k€
*
with national mission 400 k€
without national mission 200 k€
Q26 Maintenance budget 150 k€ < 100 k€ 250 k€
Q27 Usage income 50 - 100 k€ 500 k€
*
with national mission 225 k€
without national mission 100 k€
*)
 Number of answers insufficient for meaningful split.
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